Stay updated with breaking news from Neil Kumar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
– Project ‘NADER’ is intended to span multiplephases, starting from mapping rare diseases in the UAE and wider region through innovative risk assessment algorithms, and moving towards clinical trials with
UAE-based Burjeel Holdings and US-based BridgeBio Pharma have announced a new project to revolutionise the field of early diagnosis and treatment of rare diseases or disorders in the UAE and the region.
Burjeel Holdings, one of the largest healthcare providers in
BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) shares shot up 5.9% on Wednesday . The stock traded as high as $17.40 and last traded at $17.25. 999,382 shares were traded during trading, a decline of 60% from the average session volume of 2,467,842 shares. The stock had previously closed at $16.29. Analysts Set New Price […]
BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report)’s share price dropped 3.9% during mid-day trading on Thursday . The stock traded as low as $17.19 and last traded at $17.31. Approximately 1,190,509 shares changed hands during mid-day trading, a decline of 52% from the average daily volume of 2,470,749 shares. The stock had previously closed at […]